Drug intelligence / Profile preview

curcumenol

Development stage
Preclinical
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical, Intravenous, Intraperitoneal
01

Overview

Curcumenol is a sesquiterpenoid compound and one of the major bioactive components of Zedoary turmeric oil (from Curcuma zedoaria and related Curcuma species)[1][2][9]. It has been reported to possess a range of biological activities including anti-inflammatory[1][2], neuroprotective[2][3], hepatoprotective[2], antibiotic/antibacterial (notably against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa)[9], and anticancer effects[7]. Mechanistically it inhibits NF-kappaB activation by suppressing nuclear translocation of the NF-kappaB p65 subunit and blocking IκBα phosphorylation/degradation; it also inhibits cytochrome P450 isoform CYP3A4 competitively in vitro but is not considered a mechanism-based inhibitor at clinically relevant concentrations[7]. Its main source is the rhizome of Curcuma zedoaria.

Other names
curcumenol(+)-curcumenol6H-3a,6-Epoxyazulen-6-ol, 1,2,3,4,5,8a-hexahydro-3,8-dimethyl-5-(1-methylethylidene)-, (3S-(3-alpha,3a-alpha,6-alpha,8a-beta))5-beta-guiaia-7(11),9-dien-8-alpha‑ol, 5,8‑epoxy-(1S,2S,5S,8R)-2,6-dimethyl‑9-propan‑2‑ylidene‑11‑oxatricyclo[6.2.1.01 ,5]undec‑6-en‑8–ol
02

Targets

CYP3A4 (Cytochrome P450 3A4)

Beyond the preview

Go deeper on curcumenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on curcumenol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call